Staar Surgical Board Authorizes $50 Million Share Repurchase Program
Question
Staar Surgical Board Authorizes $50 Million Share Repurchase Program
Direct answer
Direct corporate open-market equity repurchases reduce float and provide balance-sheet support for STAA valuation. — bullish pressure on STAA via float reduction via open market share repurchases.
- Original publisher
- Market Ontology
- Evidence through
- 2026-09-27
- Published
- 2026-10-20
- Revision
- 1 · 2026-10-20
Cite as: Market Ontology, “Staar Surgical Board Authorizes $50 Million Share Repurchase Program”, revision 1, evidence through 2026-09-27. https://marketontology.com/catalysts/2026-09-27/staar-surgical-board-authorizes-50-million-share-repurchase-program-def3dc
| Asset | Direction | Timeframe | Channel | Score |
|---|---|---|---|---|
| STAA | ▲Bull | 1–5 days | float reduction via open market share repurchases | 49 |
Staar Surgical Board Authorizes $50 Million Share Repurchase Program
Direct corporate open-market equity repurchases reduce float and provide balance-sheet support for STAA valuation. — bullish pressure on STAA via float reduction via open market share repurchases.
Staar Surgical announced a $50 million share buyback program, causing the stock to surge 7.5%.
- SourceStaar Surgical announced a $50 million share buyback program, causing the stock to surge 7.5%.
- TransmissionDirect corporate open-market equity repurchases reduce float and provide balance-sheet support for STAA valuation.
- SummaryStaar Surgical approved a $50 million share repurchase program. Shares rallied 7.5% on the announcement. Management highlighted balance sheet liquidity and undervaluation.
- STAADirect directional exposure
Illustrative, not advice
- Crowded positioning may already reflect the move
- Counter-catalyst could neutralize the thesis before window closes
- STAA closes below pre-catalyst level on rising volume
- Catalyst narrative is officially walked back or contradicted
- Cross-asset confirmation (rates / FX / vol) reverses direction
- STAA price vs. pre-event level
- STAA volume vs. 20-day average
What happened next
| Asset | Call | Base close | +1 day | +5 days | +20 days |
|---|---|---|---|---|---|
| STAA | Bullishagreed | 20.51 2026-09-25 | +1.76% | +9.56% | Pending |
Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.
No verifiable public source recorded for this card.
Related catalysts
- 2026-09-30Staar Surgical Rallies 8% Following Stifel Upgrade to Buy and $31 TargetSF STAA-1.11%
- 2026-09-30Staar Surgical Rallies 8% on Stifel Rating Upgrade and Higher Price TargetSTAA-1.11%
- 2026-09-30Staar Surgical Rallies 8% on Stifel Rating Upgrade and Higher Price TargetSTAA-1.11%
- 2026-09-30Staar Surgical Rallies 8% on Stifel Upgrade and Lens Demand OutlookSTAA-1.11%
- 2026-09-27Staar Surgical Board Authorizes $50 Million Share Buyback ProgramSTAA+9.56%
- 2026-09-27Staar Surgical Board Authorizes $50 Million Share Repurchase ProgramSTAA+9.56%
- 2026-09-27Staar Surgical Rallies 7.5% Following Board Approval of $50 Million Buyback ProgramSTAA+9.56%
- 2026-09-27Staar Surgical Board Authorizes $50 Million Share Repurchase ProgramSTAA+9.56%
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.